missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VSIG1 Fc Chimera Protein
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
Measured by its ability to inhibit anti-CD3 antibody induced IL-17 secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 5-25 μg/mL.
Specifications
Specifications
| Accession Number | Q86XK7-1 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Gene ID (Entrez) | 340547 |
| Molecular Weight (g/mol) | M.W. (Observed): 68-84 kDa, reducing conditions; M.W. (theoretical): 50 kDa |
| Name | Cell surface A33 antigen, dJ889N15.1, Glycoprotein A34, GPA34, MGC44287,1700062D20Rik, V-set and immunoglobulin domain containing 1, V-set and immunoglobulin domain-containing protein 1 |
| Quantity | 50 μg |
| Source | Mouse myeloma cell line, NS0-derived human VSIG1 protein Human VSIG1 (Val22-Gly234) (N-terminus) Accession # Q86XK7-1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction